JLL said Friday it completed the $94.5 million sale of 95 Greene St., a 337,888-square-foot commercial building in Jersey City to Thor Equities Group, a New York City-based real estate leader with a growing life sciences portfolio.

95 Greene St. served as a primary manufacturing facility for Colgate Palmolive until 1987 and was later converted into a Class A office building that was occupied by Merrill Lynch for many years.

JLL Vice Chairman Daniel Loughlin, Senior Managing Director and co-Head of Capital Markets in New Jersey Jose Cruz, Executive Vice President and co-Chair of the Life Sciences Advisory John Cunningham, Executive Vice President Blake Goodman and Senior Vice President John Cahill represented the seller.

Thor Equities selected JLL to continue serving as the exclusive leasing agent at 95 Greene St.

“Thor Equities is a diverse real estate firm with a dedicated life sciences investment platform,” said Loughlin. “It is committed to a multimillion-dollar capital investment program repositioning the building to a ‘lab ready’ condition enabling expedited delivery of tenant lab improvements and speed to market. More importantly, the property is uniquely entitled for R&D and specialty uses. The building’s legacy manufacturing infrastructure provides a highly capable environment for all types of research functions.”

“Many businesses in New York do not realize that 95 Greene St. is easier to get to then most of New York City’s current life science offerings,” added Cahill.

Located at the intersection of Greene and York streets, 95 Greene St. is in Jersey City’s Paulus Hook neighborhood with views of the Statue of Liberty and Hudson waterfront.

The property is a short walk from the Exchange Place PATH Station, New York Waterway Ferry and the new Hudson-Bergen Light Rail system.